Table 3. Summary of NGS results from NIPGS and TE samples obtained from the same blastocyst in fresh cases.

Sample Number	TE biopsy	NIPGS	WGA DNA concentration in NIPGS
1	XY; normal	XY; mosaic -8 (70%)	16.9 ng/μl
2	XY; mosaic loss: (-4q31.3-q35.2, 32.9Mb, 20%)	XY; mosaic gain: (+4q 22.1-q35.2, 94.3Mb, 30%)	30.0 ng/μl
3	XY; -5, -13	XY; -5, -13	26.0 ng/μl
4	XY; mosaic -9 (30%)	XY; normal	22.5 ng/μl
5	XX; +13, +19, -21	XX; +13, +19, -21	23.7 ng/μl
6	XY; +10, -11, -20	XY; +10, -11, -20	22.6 ng/μl
7	XY; mosaic +6q22.1-q.25.2 (38.5Mb, 45%), mosaic -15 (50%)	XY; mosaic -8 (50%)	36.0 ng/μl
8	XX; normal	XX; normal	25.4 ng/μl
9	XX; normal	XX; normal	6.3 ng/μl
10	XX; -18q12.2-q23 (43.34Mb) -12q11.2–12.1 (18.89Mb)	XX; -18q12.2-q23 (43.34Mb) -12q11.2–12.1 (18.89Mb)	9.3 ng/μl
11	XY; mosaic -4q (118.6Mb, 20%)	XY; mosaic +13q21.1–31.3 (34.84Mb, 60%)	11.7 ng/μl
12	XX; normal	XX; normal	17.1 ng/μl
13	XX; normal	XX; normal	11.4 ng/μl
14	XX; mosaic loss: (-3p.26.3 –p25.2, 12Mb, 35%)	XX; normal	21.0 ng/μl
15	XX; -14	XX; -14	14.0 ng/μl
16	XX; normal	XX; normal	6.44 ng/μl
17	XY; normal	XY; normal	14.4 ng/μl
18	XX; -15	XX; -15	13.1 ng/μl
19	XY; +16, +21`	XY; +16, +21	22.9 ng/μl

TE = Trophectoderm

NIPGS = Non-invasive preimplantation genetic screening